We understand and appreciate the complexities involved in sourcing the most appropriate medication. We use our science-based approach, operational expertise and global experience to effectively, ethically and efficiently specify, source and supply comparators and devices.
We use our science-based approach, operational expertise, and global experience to effectively, ethically, and efficiently specify, source, and supply comparators and devices.
Vanessa started her career as a research associate at Scotland Yard and then joined LGC Group. Subsequently, she joined IQVIA where she worked with some of the largest biopharmaceuticals and biotechs to provide innovative solutions.
She has extensive experience in drug development from preclinical to registration and commercialisation strategies. She has secured product registration for several orphan and first-in-class drugs. She was also Chief Commercial Officer in a leading technology provider for patient access to clinical trials.
Vanessa was Senior Advisor to DiGamma Capital. She is on the Enterprise Advisory Board of CW+ and undertakes extensive charity work. She has a PhD in Cardiovascular Genetics from UCL, an MBA from Cambridge and a Masters Degree in Market Access from the University of Lyon.
Maurizio has over 30 years’ experience in investment banking. He has interests and expertise in healthcare and a keen eye for early-stage innovative biotech and medtech companies.
Maurizio was on the Board of Molmed SpA, listed in Milan, and on the Board of Lay Line Genomics. Before joining CSI, he was a Financial Advisor of San Raffaele Hospital, Milan, and a Fund Manager of Luxembourg SICAV (Long-Short Strategy European stocks).
He started his career as Head of New Issues, Schroders, and subsequently Managing Director, Capital Markets, Citigroup. He is an Honorary Member of the Italian Medical Society of Great Britain. Maurizio earned his BSc in Anthropology from UCL, and Masters Degree in Economics from LSE.
Steve is a veteran of the pharmaceutical industry having started his career at Pfizer in research, development and formulation of novel compounds. Subsequently, he worked as Head Pharmacist in some of the largest NHS Trust Hospitals in the UK where he gained invaluable experience in stock control, manufacturing, clinical trials and validation procedures.
Steve moved back to the Pharmaceutical and Manufacturing Industry and has extensive expertise in all aspects of site quality and regulatory compliance, (MHRA and ISO), third party EUGMP audits, QP product release on MIA (IMP) license, Responsible Person and Quality Controller.
Steve is a Member of the Royal Pharmaceutical Society of Great Britain, Member of the General Pharmaceutical Council and Member of the Joint Pharmaceutical Analysis Group. Steve is a qualified Pharmacist B.Pharm. (Hons) and has a Diploma in Psychiatric Pharmacy.
Kotaro has been in Investment Banking businesses over 23 years. He has worked with pharmaceutical manufactures and grown his interests in biochemicals and meditechs as well through the investment banking business activities.
He started his career in Tokyo as a retail sales branch manager then expanded his expertise to wholesale and internationally in Amsterdam and London within the industry. He also worked for Sony Corporation at the global headquarters in Tokyo in 1998 and joined staring-up an online brokerage firm. During his position at Deutsche Bank AG London in the Global Market Division for nearly 10 years since 2003, he obtained the Leave to Remain in the UK VISA to become a local employee. He supported major listed Japanese Pharmaceutical companies and also many related firms in the industry through supporting their Investor Relations activities from London not just in the UK and Europe region but globally.
He has cultivated his career diversified in ESG (Environmental, Social and Governance) area and organized a Japan featuring ESG conference with the Financial Times in London in 2019.
He has a bachelor degree of Social Science and Economics at Waseda University.
John Morell Frellsen
John Morell Frellsen, Growth Advisor John Morell Frellsen is an experienced executive with a successful history of working with purchasing, sales, and distribution of pharmaceuticals on a worldwide basis.
John has a real entrepreneurial spirit and a strong track record in delivering rapid revenue growth, developing commercial teams and distribution networks. He has successfully built-up two sales organisations and he has founded and developed three own companies. He is passionate about customer service, innovation, and patient access to medicines. John has a Master’s Degree from the University of Southern Denmark in Business Economics and Languages.
In addition, John has completed several educational programs at INSEAD, France.
We are always seeking the most innovative scientific talent to join our team. Please get in touch
Put our team to the test. Request a callback and we'll contact you right away.